Approval · Notice of Compliance 7734 · 2006
FOSAVANCE: Notice of Compliance 7734
Issued February 3, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7734
- Date
- February 3, 2006
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FOSAVANCE | 02276429 | Marketed |
Medicinal ingredients
- ALENDRONIC ACID 70 MG per TAB
- VITAMIN D3 2,800 UNIT per TAB